A phase I trial combining decitabine/dendritic cell vaccine...

Cancer Immunology, Immunotherapy 2015 / 10 Vol. 64; Iss. 10

A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

Krishnadas, Deepa K., Shusterman, Suzanne, Bai, Fanqi, Diller, Lisa, Sullivan, Janice E., Cheerva, Alexandra C., George, Rani E., Lucas, Kenneth G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
64
Language:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-015-1731-3
Date:
October, 2015
File:
PDF, 683 KB
english, 2015
Conversion to is in progress
Conversion to is failed